Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kwee Yong

Showing results (41-50 of 187) with videos related to

Pageof 19
Sort By:
Frontiers in Oncology|April 23, 2024
Co-operation of MCL-1 and BCL-X<sub>L</sub> anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicityDaria Galas-Filipowicz, Selina J Chavda, Jia-Nan Gong, et al.
British Journal of Haematology|November 23, 2021
Applying current smouldering myeloma risk models to a UK single-centre cohort and clinical features at progressionLouise Ainley, Marquita Camilleri, Selina J Chavda, et al.
Haematologica|April 13, 2004
Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathwayNino Porakishvili, Lela Kardava, Andrew P Jewell, et al.
Ejhaem|April 18, 2024
Challenges in designing and running smouldering myeloma interventional clinical trialsCatherine Lecat, Eileen M Boyle, Daniel Hughes, et al.
Thrombosis Research|March 12, 2022
Safety and efficacy of apixaban as thromboprophylaxis in myeloma patients receiving chemotherapy: A prospective cohort studyZara Sayar, Carolyn Gates, Sotirios Bristogiannis, et al.
British Journal of Haematology|January 13, 2015
RAS mutation status and bortezomib therapy for relapsed multiple myelomaDean Smith, Elena Armenteros, Laura Percy, et al.
European Journal of Cancer Care|April 28, 2011
Relapsed multiple myeloma in the UK prior to the introduction of novel agents--a response to Koleva et al. (2010)John Quinn, Fran Percival, Martin Auger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2003
Reconstitution of T-cell repertoire after autologous stem cell transplantation: influence of CD34 selection and cytomegalovirus infectionKarl S Peggs, Stephanie Verfuerth, Arnold Pizzey, et al.
Journal of Interprofessional Care|January 17, 2019
Interprofessional bedside rounds: Nurse-physician collaboration and perceived barriers in an Asian hospitalBi Hui Chew, Charmaine Jinxiu Tang, Wee Shiong Lim, et al.
Ejhaem|January 27, 2025
Real-world characteristics and outcomes of patients with multiple myeloma receiving second-line treatment in EnglandSally Moore, Laura Cornic, Christina-Jane Crossman-Barnes, et al.
Pageof 19

Showing results (41-50 of 187) with videos related to

Sort By:
Pageof 19
Frontiers in Oncology|April 23, 2024
Co-operation of MCL-1 and BCL-X<sub>L</sub> anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicityDaria Galas-Filipowicz, Selina J Chavda, Jia-Nan Gong, et al.
British Journal of Haematology|November 23, 2021
Applying current smouldering myeloma risk models to a UK single-centre cohort and clinical features at progressionLouise Ainley, Marquita Camilleri, Selina J Chavda, et al.
Haematologica|April 13, 2004
Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathwayNino Porakishvili, Lela Kardava, Andrew P Jewell, et al.
Ejhaem|April 18, 2024
Challenges in designing and running smouldering myeloma interventional clinical trialsCatherine Lecat, Eileen M Boyle, Daniel Hughes, et al.
Thrombosis Research|March 12, 2022
Safety and efficacy of apixaban as thromboprophylaxis in myeloma patients receiving chemotherapy: A prospective cohort studyZara Sayar, Carolyn Gates, Sotirios Bristogiannis, et al.
British Journal of Haematology|January 13, 2015
RAS mutation status and bortezomib therapy for relapsed multiple myelomaDean Smith, Elena Armenteros, Laura Percy, et al.
European Journal of Cancer Care|April 28, 2011
Relapsed multiple myeloma in the UK prior to the introduction of novel agents--a response to Koleva et al. (2010)John Quinn, Fran Percival, Martin Auger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2003
Reconstitution of T-cell repertoire after autologous stem cell transplantation: influence of CD34 selection and cytomegalovirus infectionKarl S Peggs, Stephanie Verfuerth, Arnold Pizzey, et al.
Journal of Interprofessional Care|January 17, 2019
Interprofessional bedside rounds: Nurse-physician collaboration and perceived barriers in an Asian hospitalBi Hui Chew, Charmaine Jinxiu Tang, Wee Shiong Lim, et al.
Ejhaem|January 27, 2025
Real-world characteristics and outcomes of patients with multiple myeloma receiving second-line treatment in EnglandSally Moore, Laura Cornic, Christina-Jane Crossman-Barnes, et al.
Pageof 19